CD83 and acute graft versus host disease: Studies have shown that anti-CD83 antibodies have immunosuppressive potential thus, they can be used for the treatment of acute graft-versus-host disease (GVHD), which occurs after allogenic hematopoietic stem cell transplant due to the cascades of inflammatory reactions of donor immune cells29,30.